Biomica vs EMRIS Pharma

Biomica vs EMRIS Pharma, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Biomica is on 43/100 and EMRIS Pharma on 45/100.

Biomica logo
BiomicaBiomica is developing a novel microbiome-based platform for the treatment of cancer.
Try Biomica
EMRIS Pharma logo
EMRIS PharmaDeveloping topical treatments to prevent and treat skin toxicities from cancer therapies.
Try EMRIS Pharma

Where each one leads

Biomica

  • agent readiness: 37/100 against 30/100

EMRIS Pharma

  • domain rating: 10/100 against 9/100

At a glance

MeasureBiomicaEMRIS Pharma
What it isBiomica is developing a novel microbiome-based platform for the treatment of cancer.Developing topical treatments to prevent and treat skin toxicities from cancer therapies.
CategoryLife Sciences, Biotech, Drug Discovery, Microbiome EngineeringLife Sciences, Oncology, Biotech, MedTech
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware
Founded20182021
HeadquartersRehovot, IsraelTel Aviv, Israel
StatusActiveActive

Size, funding and growth

MeasureBiomicaEMRIS Pharma
Employees77
Total funding$20.0MNot published
Latest roundFunding RoundNot published
LinkedIn followers2,7672,441

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureBiomicaEMRIS Pharma
StartupHub scoreOur 0-100 rating43/10045/100
Traction46/1009/100
Team40/10060/100
Search visibility20/10034/100
Quality45/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (37/100)F (30/100)
Domain ratingLink authority, 0-1009/10010/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureBiomicaEMRIS Pharma
HostingSelf ManagedSelf Managed
CMSNot detectedWordPress
FrameworksJqueryJquery

Biomica vs EMRIS Pharma: common questions

Which is better, Biomica or EMRIS Pharma?

On our 0-100 score EMRIS Pharma rates higher (45/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do Biomica and EMRIS Pharma compare on the numbers?

Biomica leads on agent readiness (37/100 against 30/100). EMRIS Pharma leads on domain rating (10/100 against 9/100).

Read the full Biomica review and pricing or the EMRIS Pharma review and pricing. You can also browse other Biomica alternatives we track.